Proposals under this topic aim at integrating at EU level and providing access to a wide and inclusive portfolio of complementary research infrastructure services, including data services, and customised workflows supporting R&I projects along the development pipeline from discovery research to personalised treatment of cancer. Services should also support activities addressing the socio-economic dimension of cancer, the development of evidence-based public health measures and patient-centred approaches, as well as regulatory aspects of novel biomedical products or relevant biomarkers.
Expected Outcome: Project results are expected to contribute to all the following expected outcomes:
- provision of innovative, customised and efficient RI services enhancing and increasing society’s long-term and consistent problem-solving capacity and evidence-based policy making in the health areas, including a better understanding of socio-economic implications;
- advancement of knowledge for personalised cancer prevention strategies and treatments;
- accelerated availability of solutions and products to patients in need;
- wider access to specialised R&I services to underpin the competitiveness of the European industry and of biotech SMEs developing new personalised cancer prevention strategies and treatments.
Deadline date: 23 September 2021 17:00:00 Brussels time